Fig. 2From: Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trialPeripheral Blood Collection Timeline. Study completion is defined as 5 years of follow-up. Sample 1A & 1B will include 2 vials of blood for ctDNA and peripheral blood mononuclear cell isolationBack to article page